YMRC
RTO icon

Yorktown Management & Research Company’s Rentokil RTO Stock Holding History

Yorktown Management & Research Company’s Portfolio RTO Stock Details RTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,900
Closed -$298K – 231
2024
Q1 		$298K Buy
+9,900
New +$275K 0.28% 171

Other funds holding RTO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
GCM
Gates Capital Management New York $3.66B AUM 12.63% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Yorktown Management & Research Company's RTO Position: Q2 2024 in Review

Yorktown Management & Research Company sold out of Rentokil (RTO) in Q2 2024, closing a stake of 9,900 shares — an estimated $298K sold.

Yorktown Management & Research Company first reported a position in RTO in Q1 2024 and held it in 1 quarter. The position peaked at $298K in Q1 2024. 232 funds tracked by Wall St. Rank hold RTO as of Q2 2024.

  • Yorktown Management & Research Company reported no remaining Rentokil position as of Q2 2024 after selling out during the quarter.
  • Yorktown Management & Research Company sold 9,900 Rentokil shares in Q2 2024, an estimated $298K.
  • Yorktown Management & Research Company first reported a position in Rentokil in Q1 2024 and held it in 1 quarter.
  • Yorktown Management & Research Company's Rentokil position peaked at $298K in Q1 2024.
  • 232 funds tracked by Wall St. Rank held Rentokil as of Q2 2024.

Based on Yorktown Management & Research Company's 13F filing for Q2 2024, filed 30 Jul 2024.